Physician profile
Brian Mark Thomas
NPI 1851836134
$2,039.95
in general payments reported to CMS, 2019-2025
15 companies · $993 in 2025
The $993 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $86.81 · 2023: $543 · 2024: $417 · 2025: $993.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,885 · Education: $68.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,885.14 |
| Education | $68.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $677.45 | 2023-2025 | Lithovue, Rezum Generator, Ams 700 |
| Janssen Biotech, INC. | $229.43 | 2025 | Erleada |
| Calyxo, INC. | $150.46 | 2024-2025 | Cvac Aspiration System |
| Stryker Corporation | $145.97 | 2024 | 1788 |
| Janssen Scientific Affairs, LLC | $144.62 | 2023 | Erleada |
| Teleflex LLC | $134.76 | 2023 | Urolift |
| C. R. Bard, INC. & Subsidiaries | $122.02 | 2025 | Bard Urinary Drainage Bag |
| Bayer Healthcare Pharmaceuticals INC. | $110.80 | 2022-2025 | |
| Procept Biorobotics Corporation | $108.86 | 2024 | Aquabeam System |
| Cook Medical LLC | $71.72 | 2024 | Cook |
| Novartis Pharmaceuticals Corporation | $43.85 | 2025 | |
| Abbvie INC. | $35.30 | 2025 | |
| Urogen Pharma, INC. | $26.67 | 2025 | |
| Janssen Pharmaceuticals, INC | $19.39 | 2024 | Xarelto |
| Davol INC. | $18.65 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.